Immunome, Inc. (IMNM) Financials
IMNM Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| June 30, 2026 | 565.4 million | 40.3 million |
| March 31, 2026 | 619.8 million | 31.1 million |
| Dec. 31, 2025 | 683.2 million | 48.8 million |
| Sept. 30, 2025 | 299.4 million | 35.5 million |
IMNM Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| June 30, 2026 | -63.9 million | 8.8 million |
| March 31, 2026 | -61.6 million | 8.0 million |
| Dec. 31, 2025 | -52.0 million | 7.9 million |
| Sept. 30, 2025 | -41.6 million | 6.7 million |
IMNM Net Income
No data available :(
IMNM Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| June 30, 2026 | 520.0 million | 4.6 million | - |
| March 31, 2026 | 582.7 million | 3.7 million | 3.7 million |
| Dec. 31, 2025 | 653.5 million | 3.9 million | 3.9 million |
| Sept. 30, 2025 | 272.6 million | 4.0 million | 4.0 million |
IMNM Shares Outstanding
IMNM Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| June 30, 2026 | 2.2 million | 59.9 million | 18.3 million | - |
| March 31, 2026 | 3.0 million | 46.4 million | 13.0 million | - |
| Dec. 31, 2025 | 4.0 million | 60.8 million | 12.1 million | - |
| Sept. 30, 2025 | 1.1 million | 49.2 million | 10.9 million | - |
IMNM Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| June 30, 2026 | - | - |
| March 31, 2026 | - | 753000 |
| Dec. 31, 2025 | - | 776000 |
| Sept. 30, 2025 | - | 49.2 million |
IMNM
Price: $27.20
52 week price:
Earnings Per Share: -2.39 USD
Exchange: NCM
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 8759
Market Capitalization: 3.0 billion